Global Mycoplasma Testing Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	152 Pages	Coherent Market Insights	January, 2024	CMI18533605

Best Price Guarantee
Price	from $4,500
Length	152 Pages
Publisher	Coherent Market Insights
Published Date	January, 2024
SKU	CMI18533605

Global Mycoplasma Testing Market, By Product Type (Kits & Reagents, Instruments), By Application (Cell Line Testing, Virus Testing, End of Production Testing, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Mycoplasma testing is essential in the field of biotechnology and pharmaceuticals. There are different types of products available in the market for mycoplasma testing. The major products can be categorized into two types - kits and services.

Kits are self-contained tools that allow researchers to test for mycoplasma contamination on their own. These kits have all the necessary reagents and instructions to perform the test. The most common types of kits are polymerase chain reaction (PCR)-based kits, enzyme-linked immunosorbent assay (ELISA) based kits, and microbiological-based kits. PCR kits are highly sensitive and specific but require specialized equipment. ELISA kits are easier to use as they don't need specialized equipment but are less sensitive than PCR. Microbiological kits involve detecting mycoplasma growth directly but take longer time to give results.

Along with kits, various companies offer mycoplasma testing as services where researchers can send their samples to specialized testing facilities. The advantage of services is that researchers do not need to invest in equipment or training. Experienced technicians at the service facilities perform different types of tests like PCR, ELISA, and microbiological assays and provide reports. However, there can be delays in getting results as samples need to be shipped. Kits allow for faster testing but require proper infrastructure. Both products have their advantages in different situations depending on individual lab requirements and capacities.

Market Dynamics:

Growing research and development (R&D) activities by the market players is expected drive the market growth over the forecast period. Moreover, increasing organic and inorganic strategies by the market players will aid in the market growth over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global mycoplasma testing market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mycoplasma testing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories International, Merck KGaA, Lonza Group Ltd, Roche Diagnostics, Thermo Fisher Scientific, Merck, InvivoGen, Creative Bioarray, and Other Prominent Players
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mycoplasma testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mycoplasma testing market

Detailed Segmentation:

Global Mycoplasma Testing Market, By Product Type
Kits & Reagents
Instruments
Global Mycoplasma Testing Market, By Application
Cell Line Testing
Virus Testing
End of Production Testing
Others (Raw Material Testing, etc.)
Global Mycoplasma Testing Market, By End User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Global Mycoplasma Testing Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Top Companies in the Global Mycoplasma Testing Market:
Charles River Laboratories International.
Merck KGaA
Lonza Group Ltd
Roche Diagnostics
Thermo Fisher Scientific
Merck
InvivoGen
Creative Bioarray
Other Prominent Players

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Product Type; Market Snippet, By Application; Market Snippet, By End User; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rising research and development activities by the market players; Increasing R&D Expenditure; Key Highlights; Regulatory Scenario; Recent Trends; PEST Analysis; PORTER’s Analysis; Mergers, Acquisitions, and Collaborations
4. Global Mycoplasma Testing Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Mycoplasma Testing Market, By Product Type, 2019-2031, (US$ Mn): Introduction; Market Share Analysis, 2024 and 2031(%); Y-o-Y Growth Analysis, 2020– 2031; Segment Trends; Kits & Reagents; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); Instruments; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
6. Global Mycoplasma Testing Market, By Application, 2019-2031, (US$ Mn): Introduction; Market Share Analysis, 2024 and 2031(%); Y-o-Y Growth Analysis, 2020 – 2031; Segment Trends; Cell Line Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); Virus Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); End of Production Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); Others (Raw Material Testing, etc.); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
7. Global Mycoplasma Testing Market, By End User, 2019-2031, (US$ Mn): Introduction; Market Share Analysis, 2024 and 2031(%); Y-o-Y Growth Analysis, 2020 – 2031; Segment Trends; Pharmaceutical & Biotechnology Companies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); Contract Research Organizations; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn); Academic Research Institutes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
8. Global Mycoplasma Testing Market, By Region, 2019-2031, (US$ Mn): Introduction; Market Share Analysis, By Region, 2024 and 2031(%); Y-o-Y Growth Analysis, For Region, 2020–2031; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn); U.S.; Canada; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn); Germany; U.K.; Spain; France; Italy; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn); Brazil; Argentina; Mexico; Rest of Latin America; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn); GCC Countries; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn); North Africa; Central Africa; South Africa
9. Competitive Landscape: Company Profile; Charles River Laboratories International; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Merck KGaA; Lonza Group Ltd; Roche Diagnostics; Thermo Fisher Scientific; Merck; InvivoGen; Creative Bioarray; Other Prominent Players; Analyst Views
10. Section: References; Research Methodology; About us; *Browse 35 market data tables and 31 figures on “Global Mycoplasma Testing Market” - Global forecast to 2031